Quadrature Capital Ltd

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-13
Total Holdings
1,032
Total Value
4509523701
Accession Number
0001651424-25-000006
Form Type
13F-HR
Manager Name
Quadrature Capital Ltd
Data Enrichment
80% identified
825 identified207 unidentified

Holdings

1,032 positions
Manager:
Search and click to pin securities to the top
Page 52 of 52
C4 Therapeutics, Inc.
Shares:
16009
Value:
$25.5M
ACELYRIN, Inc.
Shares:
10246
Value:
$25.3M
Alto Neuroscience, Inc.
Shares:
11402
Value:
$24.7M
Ventyx Biosciences, Inc.
Shares:
21148
Value:
$24.5M
Commercial Vehicle Group, Inc.
Shares:
21061(-1.4%)
Value:
$24.4M(-54.1%)
SELLAS Life Sciences Group, Inc.
Shares:
20673
Value:
$22.2M
Larimar Therapeutics, Inc.
Shares:
10242
Value:
$21.9M
Metagenomi, Inc.
Shares:
14198
Value:
$19.5M
BTCS Inc.
Shares:
11655
Value:
$17.5M
Alector, Inc.
Shares:
12949
Value:
$16.0M
InflaRx N.V.
Shares:
13858
Value:
$14.4M
STANDARD LITHIUM LTD.
Shares:
10442
Value:
$13.4M